Cargando…
Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
JKL International LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676780/ https://www.ncbi.nlm.nih.gov/pubmed/37199595 http://dx.doi.org/10.14336/AD.2023.0502 |
| _version_ | 1785149977339625472 |
|---|---|
| author | Feng, Dechao Li, Dengxiong Wu, Ruicheng Han, Ping |
| author_facet | Feng, Dechao Li, Dengxiong Wu, Ruicheng Han, Ping |
| author_sort | Feng, Dechao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10676780 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | JKL International LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106767802023-12-01 Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium Feng, Dechao Li, Dengxiong Wu, Ruicheng Han, Ping Aging Dis Letter to the Editor JKL International LLC 2023-12-01 /pmc/articles/PMC10676780/ /pubmed/37199595 http://dx.doi.org/10.14336/AD.2023.0502 Text en Copyright: © 2023 Feng et al. https://creativecommons.org/licenses/by/2.0/this is an open access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
| spellingShingle | Letter to the Editor Feng, Dechao Li, Dengxiong Wu, Ruicheng Han, Ping Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title | Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title_full | Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title_fullStr | Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title_full_unstemmed | Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title_short | Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium |
| title_sort | scientific advancements in drug development and trials for urothelial carcinoma: insights from the 2023 asco-gu cancers symposium |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676780/ https://www.ncbi.nlm.nih.gov/pubmed/37199595 http://dx.doi.org/10.14336/AD.2023.0502 |
| work_keys_str_mv | AT fengdechao scientificadvancementsindrugdevelopmentandtrialsforurothelialcarcinomainsightsfromthe2023ascogucancerssymposium AT lidengxiong scientificadvancementsindrugdevelopmentandtrialsforurothelialcarcinomainsightsfromthe2023ascogucancerssymposium AT wuruicheng scientificadvancementsindrugdevelopmentandtrialsforurothelialcarcinomainsightsfromthe2023ascogucancerssymposium AT hanping scientificadvancementsindrugdevelopmentandtrialsforurothelialcarcinomainsightsfromthe2023ascogucancerssymposium |